Sonic Healthcare Limited (SKHHY) Stock Analysis & Winston Score
Sonic Healthcare is an Australian company that runs medical laboratories and radiology clinics. Its main job is testing blood, tissue, and other samples to help doctors figure out what is wrong with patients. It serves hospitals, doctors' offices, and individual patients across multiple countries, making it one of the largest pathology and diagnostic imaging providers in the world. Sonic makes money by charging fees for each test or scan it performs, with payments coming from government health programs, private insurers, and patients directly. The company operates primarily in Australia, Germany, the United States, the United Kingdom, and Switzerland, generating roughly $8–9 billion in annual revenue. Its competitive advantage comes from its large laboratory network, which allows it to process huge volumes of tests at lower cost than smaller rivals. The key risk is that government reimbursement rate cuts — especially in Australia and Germany, where regulators set prices — could squeeze profit margins over time.
Winston Score: 55/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (11/30)
- Growth: Good (12/20)
- Cash Flow: Strong (8/10)
- Stability: Strong (7/10)
- Valuation: Good (5/10)
- Ownership: Good (8/15)
Key Facts
Price: $15.08
Market Cap: $7.5B
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: Other OTC

